0001316175-17-000001.txt : 20171109 0001316175-17-000001.hdr.sgml : 20171109 20171109151553 ACCESSION NUMBER: 0001316175-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20171109 DATE AS OF CHANGE: 20171109 EFFECTIVENESS DATE: 20171109 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Anthera Pharmaceuticals Inc CENTRAL INDEX KEY: 0001316175 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 201852016 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-298435 FILM NUMBER: 171190433 BUSINESS ADDRESS: STREET 1: 25801 INDUSTRIAL BOULEVARD, SUITE B CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: (510) 856-5600 MAIL ADDRESS: STREET 1: 25801 INDUSTRIAL BOULEVARD, SUITE B CITY: HAYWARD STATE: CA ZIP: 94545 D 1 primary_doc.xml X0708 D LIVE 0001316175 Anthera Pharmaceuticals Inc 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA CALIFORNIA 94545 (510) 856-5600 DELAWARE None None Corporation true May Liu 25801 Industrial Boulevard, Suite B Hayward CA CALIFORNIA 94545 Executive Officer Biotechnology Decline to Disclose 06b false 2017-10-27 false true true false 0 Piper Jaffray & Co. 665 None None 800 Nicollet Mall Minneapolis MN MINNESOTA 55402-7020 All States false 2883421 2883421 0 The purchasers are irrevocably bound to purchase an additional $12,116,578.75 in securities of Anthera Pharmaceuticals, Inc. pursuant to the same securities purchase agreement under which the $2,883,421.25 in securities were sold. false 21 221062 0 If Anthera Pharmaceuticals, Inc. receives the requisite stockholder approval authorizing the additional sale of $12,116,578.75 in securities, then Piper Jaffray & Co. shall receive 7% of such proceeds or approximately $848,161.14. 0 false Anthera Pharmaceuticals Inc /s/ May Liu May Liu Senior Vice President, Finance & Administration 2017-11-09